Literature DB >> 13374159

The effects of reserpine on hypertensive patients over a period of two years.

R HODGKINSON.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; RESERPINE/therapeutic use

Mesh:

Substances:

Year:  1956        PMID: 13374159      PMCID: PMC503984          DOI: 10.1136/hrt.18.4.523

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  9 in total

1.  Antagonism studies on reserpine and certain CNS depressants.

Authors:  G CHEN; C R ENSOR
Journal:  Proc Soc Exp Biol Med       Date:  1954-12

2.  Reserpine in the treatment of hypertension; a note on the relative dosage and effects.

Authors:  R W WILKINS; W E JUDSON; R W STONE; W HOLLANDER; W E HUCKABEE; I H FRIEDMAN
Journal:  N Engl J Med       Date:  1954-03-18       Impact factor: 91.245

3.  Hypotensive action of reserpin.

Authors:  A E DOYLE; F H SMIRK
Journal:  Lancet       Date:  1954-05-29       Impact factor: 79.321

4.  Cardiovascular and respiratory effects of serpasil, a new crystalline alkaloid from Rauwolfia serpentina Benth, in the dog.

Authors:  J H TRAPOLD; A J PLUMMER; F F YONKMAN
Journal:  J Pharmacol Exp Ther       Date:  1954-02       Impact factor: 4.030

5.  [Reserpin, the sedative principle from Rauwolfia serpentina B].

Authors:  J M MULLER; E SCHLITTLER; H J BEIN
Journal:  Experientia       Date:  1952-09-15

6.  [Serpasil, an alkaloid of Rauwolfia serpentina, in therapy of hypertension].

Authors:  L HENSLER
Journal:  Schweiz Med Wochenschr       Date:  1953-11-28

7.  Human pharmacology of reserpine.

Authors:  T WINSOR
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

8.  [Experimental studies on serpasil (reserpin) a new and very effective Rauwolfia alkaloid with analeptic effect].

Authors:  H J BEIN; F GROSS; J TRIPOD; R MEIER
Journal:  Schweiz Med Wochenschr       Date:  1953-10-17

9.  Reserpine (serpasil) in the treatment of hypertension.

Authors:  W HUGHES; E DENNIS; R McCONN; R FORD; J H MOYER
Journal:  Am J Med Sci       Date:  1954-07       Impact factor: 2.378

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.